Scor to Buy Back 5.01% Stake From Covea, Sell It to BNP Paribas Cardif
By Adria Calatayud
Scor plans to buy back a 5.01% stake in its own shares from French insurance company Covea for 252 million euros ($264.7 million) and to sell it to BNP Paribas's insurance business BNP Paribas Cardif.
French reinsurer Scor said late Wednesday that its board authorized the acquisition of 9 million of its own shares, exercizing an option contemplated by a 2021 agreement with Covea to settle a dispute that began with a failed hostile takeover attempt of Scor by Covea.
Under the settlement, Covea granted Scor a call option on its full stake of 8.8% at a price of EUR28 a share. Scor's shares closed at EUR28.60 on Wednesday.
Scor said it intends to subsequently sell its shares to BNP Paribas Cardif at an undisclosed price.
"These transactions aim to normalise Scor's shareholding," the company said.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 05, 2023 01:48 ET (05:48 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?